Skip to content

Clinical trials

Phase 2 Carcinoma, Transitional Cell trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Transitional Cell Phase: Phase 2 Status: Unknown status Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20141
20151
20173
20183
20192
20204
20214
20222
20234

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status25

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tianjin Medical University Second Hospital2
AIO-Studien-gGmbH1
Abbisko Therapeutics Co, Ltd1
Associació per a la Recerca Oncologica, Spain1
Chinese Academy of Medical Sciences1
Erasmus Medical Center1
Genta Incorporated1
Jiangsu HengRui Medicine Co., Ltd.1
Jun Guo1
MultiVir, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Transitional Cell25
Urinary Bladder Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Endometrial Neoplasms2
Melanoma2
Stomach Neoplasms2
Uterine Cervical Neoplasms2
Biliary Tract Neoplasms1
Breast Neoplasms1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.